ACTU · Actuate Therapeutics, Inc.
$1.18
-0.08 (-6.35%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$28.23M
Shares
23.93M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-07-07 | New | Pharmaceuticals | $9,330,958 | $4,665,479 | 06b |
| 2025-04-10 | New | Pharmaceuticals | $50,000,000 | $0 | 06b |
| 2024-03-06 | New | Pharmaceuticals | $5,000,000 | $3,000,000 | 06b |
| 2022-12-15 | Amendment | Pharmaceuticals | $50,000,000 | $19,336,491 | 06b |
| 2022-10-19 | New | Pharmaceuticals | $50,000,000 | $11,170,000 | 06b |
| 2020-12-10 | New | Pharmaceuticals | $50,000,000 | $14,482,301 | 06b |
Showing 1–6 of 6 filings
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
12 filings
12 filers
Visit website
Investor relations